Fig. 2From: Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapyKaplan-Meier curves of progression-free survival in advanced NSCLC patients stratified by the AFR. A low AFR was significantly associated with a worse progression-free survival than a high AFR (P = 0.008). AFR, albumin-to-fibrinogen ratio; NSCLC, non small-cell lung cancersBack to article page